Delivery Order SPE2DR25D3501-SPE2DR26FL9WS
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Journavx 50 mg tablets (30-count units) valued at $1,561.55. This non-set-aside, competitively awarded contract employs firm fixed pricing and carries an ultimate completion date of August 27, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $4,706.84 to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Journavx 50 mg tablets (30-count units). This competitively awarded, firm fixed-price delivery order is scheduled for completion by November 7, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's broader pharmaceutical supply relationship with the federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for supply of Journavx 50 mg tablets (30-count packaging) valued at $3,048.36. This firm fixed-price delivery order, with an ultimate completion date of September 15, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was made...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Journavx 50 mg tablets (30-count units) valued at $1,808.88 under a firm fixed-price arrangement. This non-set-aside, competitively awarded delivery order is scheduled for completion by October 29, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract action under...
- The Defense Logistics Agency awarded a $2,111.64 delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Journavx 50 mg tablets (100-count unit dose packaging). This firm fixed-price contract, which is not set-aside and is competitively awarded, will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 28, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Journavx 50 mg tablets in unit dose packaging (100 count) under a firm fixed price contract valued at $1,239.88. This delivery order, issued on October 29, 2025, represents a child contract under the larger Indefinite Delivery Contract vehicle and requires completion by October 30, 2025. The award was made through open competition with no set-aside designation, demonstrating the contractor's...
- The Defense Logistics Agency awarded a delivery order valued at $12,518.12 to AmerisourceBergen Drug Corp for Journavx 50 mg tablets (30-count packaging) on June 25, 2025, with an ultimate completion date of June 26, 2025. This firm fixed-price delivery order was competitively awarded without a set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Journavx 50 mg tablets (30-count units) at a ceiling value of $1,014.62. This is a firm fixed-price delivery order with no set-aside designation, representing a competitively awarded contract. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, and the order is scheduled for completion by July 15, 2025. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $6,943.92 to AmerisourceBergen Drug Corp for the supply of JOURNAVX 50 MG tablets (30-count units) on November 24, 2025, with an ultimate completion date of November 25, 2025. This firm fixed-price delivery order was competitively awarded without a set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor...
- This delivery order, awarded to AmerisourceBergen Drug Corp on November 12, 2025, provides for the supply of Journavx 50 mg tablets (30-count units) with a ceiling value of $14,471.04 under firm fixed-price terms. The award is not set-aside and represents a competitive procurement by the Defense Logistics Agency, a component of the Department of Defense responsible for managing the supply chain for military and federal healthcare systems. The place of performance is AmerisourceBergen's corporate...
- SPE2DR25D3501Indefinite Delivery Contract
- SPE2DR25D3501-SPE2DR26FL9WSDelivery Order
The Defense Logistics Agency awarded a $3,617.76 delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Journavx 50 mg tablets (30-count units). This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The contract involves no set-aside designation and specifies performance at the contractor's facility in Conshohocken, Pennsylvania, with a completion deadline of December 5, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company maintains an extensive portfolio of pharmaceutical and medical supply deliveries through DLA's Medical Supply Chain, distributing brand-name and generic medications, vaccines, and specialized medical commodities across multiple therapeutic domains. This delivery order for Journavx aligns with the company's established role as a primary pharmaceutical supplier to the Defense Health Agency and other federal healthcare customers through its comprehensive global pharmaceutical support vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.6k | 12/3/25 |